Have confidence in
for BREO

Get information for your location
Have confidence in coverage for BREO Nationally, BREO has 4 million more commercial unrestricted lives than Symbicort*
*Managed Markets Insight & Technology, LLC database as of April 2018
BREO Unrestricted Commercial Coverage 164 Million; Symbicort Unrestricted Commercial Coverage 160 Million.
Patients are reimbursed from a health plan with no accompanying step edits or prior authorizations.
Individual access may vary by geography and plan benefit design.
“Unrestricted coverage” means reimbursement from a health plan without accompanying step edits or prior authorizations. Commercial lives calculation does not include patient lives associated with Indian Health Services or Department of Veterans Affairs.
What you need to know about this formulary information
Formulary status may vary and is subject to change. Formulary comparisons do not imply comparable indications, safety, or efficacy. This is not a guarantee of partial or full coverage or payment. Consumers may be responsible for varying out-of-pocket costs based on an individual’s plan and its benefit design. Each plan administrator determines actual benefits and out-of-pocket costs per its plan’s policies. Verify coverage with plan sponsor.

The brands listed, with the exception of BREO and ELLIPTA, are trademarks or registered trademarks of their respective owners and are not trademarks of the GSK group of companies. The makers of these brands are not affiliated with and do not endorse GSK or its products.


Looking for samples?
Looking for a savings offer?
Subject to eligibility. Restrictions apply.